CMS proposes changes to increase Medicaid drug price transparency
The Centers for Medicare & Medicaid Services this week proposed changes to the Medicaid Drug Rebate Program intended to improve manufacturer data integrity and help states verify drug prices. CMS will accept comments on the proposed rule through July 25.
Related News Articles
Headline
Medicaid disenrollments are a looming concern for hospitals already operating close to the margins, according to a new report by Kaufman Hall. For April,…
Headline
The House Energy and Commerce Subcommittee on Health May 17 considered a series of health care bills, including a number focused on provisions that would…
Headline
The Centers for Medicare and Medicaid Services released a FAQ regarding Consolidated Appropriations Act changes for states redetermining Medicaid enrollee…
Headline
A new Centers for Medicare & Medicaid Services bulletin reviews the anticipated end dates for certain COVID-19-related Medicaid and Children’s Health…
Headline
The Kaiser Family Foundation has released a tool to help monitor changes in Medicaid enrollment as states redetermine eligibility due to the end of the…
Headline
AHA opposes the Centers for Medicare & Medicaid Services’ proposal to limit patient days when calculating Medicare Disproportionate Share Hospital payments…